Amundi Asset Management US’s NEVRO CORP. NVRO Stock Holding History

Amundi Asset Management US’s Portfolio NVRO Stock Details NVRO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-24,400	Closed	-$1.52M	–	1710
2019 Q1	$1.52M	Buy	+24,400	New	+$1.15M	﹤0.01%	1144
2018 Q4	–	Sell	-74,787	Closed	-$4.26M	–	1675
2018 Q3	$4.26M	Sell	74,787 -176,653	-70%	-$11M	0.01%	954
2018 Q2	$20.1M	Buy	251,440 +38,800	+18%	+$3.22M	0.03%	519
2018 Q1	$18.4M	Buy	212,640 +52,600	+33%	+$4.25M	0.03%	511
2017 Q4	$11M	Buy	160,040 +118,486	+285%	+$9.48M	0.02%	657
2017 Q3	$3.78M	Sell	41,554 -58	-0.1%	-$4.96K	0.01%	405
2017 Q2	$3.1M	Sell	41,612 -20,803	-33%	-$1.67M	0.01%	436
2017 Q1	$5.85M	Sell	62,415 -267	-0.4%	-$24.2K	0.02%	389
2016 Q4	$4.55M	Sell	62,682 -1,559	-2%	-$133K	0.02%	419
2016 Q3	$6.71M	Buy	+64,241	New	+$5.8M	0.02%	376

Other funds holding NVRO

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Amundi Asset Management US's NVRO Position: Q2 2019 in Review

Amundi Asset Management US sold out of NEVRO CORP. (NVRO) in Q2 2019, closing a stake of 24,400 shares — an estimated $1.52M sold.

Amundi Asset Management US first reported a position in NVRO in Q3 2016 and held it in 10 quarters. The position peaked at $20.1M in Q2 2018. 162 funds tracked by Wall St. Rank hold NVRO as of Q2 2019.

Amundi Asset Management US reported no remaining NEVRO CORP. position as of Q2 2019 after selling out during the quarter.
Amundi Asset Management US sold 24,400 NEVRO CORP. shares in Q2 2019, an estimated $1.52M.
Amundi Asset Management US first reported a position in NEVRO CORP. in Q3 2016 and held it in 10 quarters.
Amundi Asset Management US's NEVRO CORP. position peaked at $20.1M in Q2 2018.
162 funds tracked by Wall St. Rank held NEVRO CORP. as of Q2 2019.

Based on Amundi Asset Management US's 13F filing for Q2 2019, filed 14 Aug 2019.